Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Tactile Systems Technology Inc's Business Segments

Tactile Systems Technology Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY
Reportable Segments
4
Per the company's own filing, this quarter
Largest Segment
Product
Total Revenue
$ 86
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/TCMD/segments
https://api.csimarket.com/api/v1/companies/TCMD/geographic
https://api.csimarket.com/api/v1/companies/TCMD/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - FY

0%largest
  • Product0%
  • Lymphedema products0%
  • Airway clearance products29.3%
  • Rental Product Service20.4%

Revenue by Reportable Segment - FY

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
ProductFY$ 143--
Lymphedema productsFY$ 136--
Airway clearance productsFY$ 2529.3%-
1 more segments available

Sign in to unlock the full Tactile Systems Technology Inc dataset.

Revenue by Product & Service Category - FY

89%largest
  • Product89.3%
  • Lymphedema products85.9%
  • Airway clearance products14.1%
  • Rental Product Service10.7%

Revenue by Product & Service Category - FY

CategoryPeriodRevenue
(Millions)
% of Total
ProductFY$ 7689.3%
Lymphedema productsFY$ 7485.9%
Airway clearance productsFY$ 1214.1%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

1 more categories available

Sign in to unlock the full Tactile Systems Technology Inc dataset.

Annual Results

Revenue Share by Reportable Segment - FY

0%largest
  • Product0%
  • Lymphedema products0%
  • Airway clearance products29.3%
  • Rental Product Service20.4%

Revenue by Reportable Segment - FY

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
ProductFY$ 143--
Lymphedema productsFY$ 136--
Airway clearance productsFY$ 2529.3%-
1 more segments available

Sign in to unlock the full Tactile Systems Technology Inc dataset.

Description of Tactile Systems Technology Inc

Tactile Systems Technology Inc. is a publicly traded medical device company focused on developing and marketing at-home therapy devices that improve circulation and reduce swelling, discomfort and pain for individuals with lymphedema, chronic venous insufficiency, and other conditions affecting the lymphatic and vascular systems.

Headquartered in Minneapolis, Minnesota, the company was founded in 1995 by a licensed physical therapist, and to date, it has continued to develop clinically proven, non-invasive, and cost-effective products that aid in the management of chronic diseases. Tactile Systems Technology primarily markets its products through direct sales and a network of distributors across the United States as well as partnering with healthcare professionals such as lymphedema and wound care therapists.

One of their primary products, the Flexitouch® system, utilizes a pneumatic compression technology to simulate the hand motion of a lymphatic therapist or clinician performing various stages of manual lymph drainage. It is indicated for the treatment of lymphedema in the arms, legs or trunk, and has been clinically demonstrated to reduce swelling, increase limb mobility and reduce the risk of infection. Another product, the Entré System, is a simplified and portable version of the Flexitouch® system, and is intended for use by patients and caregivers in the home environment.

Tactile Systems Technology has a strong commitment to research and development, and as a result, the company has obtained multiple patents for its innovative technology. The company also collaborates with leading healthcare professionals and institutions to conduct research studies aimed at improving the quality of life for patients with chronic diseases.

In addition, Tactile Systems Technology has received numerous accolades and recognitions for its outstanding contribution to the medical device industry. These include being named Forbes' "Top 100 Public Companies in America" and "Top Small Cap Growth Companies" along with various industry awards, such as the "2017 Global Frost & Sullivan Award for Growth Excellence Leadership" in the compression therapy industry.

Overall, Tactile Systems Technology's mission is to improve the lives of individuals living with chronic diseases based on its strong belief in the power of science, innovation and committed partnership with patients, healthcare professionals and the community.
Tactile Systems Technology Inc. is a specialized medical device company dedicated to the design, manufacture, and sale of innovative therapeutic solutions aimed at improving the quality of life for patients suffering from chronic diseases. With a robust portfolio that encompasses various segments, products, and services, the company effectively addresses the needs of patients around the world. Below is an extensive overview of the segments, products, and services offered by Tactile Systems Technology Inc.

Segments

1. Lymphedema
- Tactile Systems Technologys lymphedema segment is fundamentally centered around the treatment of lymphedema, which results from a buildup of lymphatic fluid, often leading to swelling, discomfort, and restricted movement. The company offers devices that promote lymphatic drainage and alleviate symptoms. These devices aim to provide patients with relief while enhancing mobility and overall quality of life. The focus on clinically proven products ensures that patients receive effective therapeutic solutions.

2. Venous Insufficiency
- The venous insufficiency segment addresses the challenges faced by patients suffering from insufficient blood flow in the lower extremities, often leading to symptoms such as leg swelling, pain, and skin changes. Tactile Systems Technology produces a range of compression garments and pneumatic devices designed to improve venous circulation. These products are crafted for ease of use, making them accessible to patients seeking relief from discomfort associated with venous issues.

3. Pressure Ulcers
- This segment focuses on the prevention and treatment of pressure ulcers, also known as bedsores, which are injuries to skin and underlying tissue resulting from prolonged pressure on the skin. Tactile Systems Technology offers devices that facilitate optimal pressure redistribution and skin care management, significantly reducing the risk of ulcer formation. The company’s commitment to preventing pressure ulcers includes the development of innovative technologies to enhance healing and comfort.

Products

1. Flexitouch
- The Flexitouch device is a pneumatic compression system that delivers a gentle, massage-like compression to the affected areas, stimulating lymphatic drainage. This FDA-approved device is clinically validated, demonstrating its effectiveness in managing lymphedema. The user-friendly design promotes patient adherence and improves clinical outcomes.

2. ACTitouch
- ACTitouch is an advanced air compression device designed to provide relief through massage-like actions that promote blood flow. The device is engineered to meet the needs of patients with venous insufficiency, combining comfort with therapeutic efficacy. Its intuitive operation makes it a valuable tool for patients seeking effective management of their condition.

3. Entr'
- Entr' represents a breakthrough in wearable therapy, resembling conventional compression stockings but enhanced with patented IntelliKnit technology. This feature enables graduated compression, providing targeted support that effectively addresses conditions such as lymphedema and venous insufficiency. The design prioritizes both functionality and aesthetic appeal, encouraging regular use among patients.

4. Soothe & Soften
- The Soothe & Soften line of skincare products is specifically formulated to care for skin subjected to medical devices. These products help alleviate irritation and chafing, thereby enhancing patient comfort. Utilizing dermatologically tested ingredients, the line supports skin integrity and promotes healing in areas affected by device use.

Services

1. Clinical Support
- Tactile Systems Technology extends its commitment to healthcare by providing clinical support to medical professionals. This service includes training on the use of devices, ensuring effective patient management, and aiding in the application of best practices in treatment. The clinical support team collaborates with healthcare providers to optimize therapeutic outcomes for patients.

2. Patient Support
- Recognizing the importance of patient education and compliance, Tactile Systems Technology offers personalized support to individuals using their devices. This service aims to empower patients through education on the correct usage of devices, lifestyle modifications, and strategies for maximized treatment benefits. The support team acts as a resource for patients, helping them navigate their therapeutic journey effectively.

3. Insurance Support
- Navigating insurance can often be a challenge for patients. Tactile Systems Technology assists patients and healthcare professionals in managing insurance-related inquiries and claims. This service ensures that patients gain access to the devices prescribed by their physicians and helps streamline the reimbursement process, alleviating some of the financial burdens associated with their treatment.

Summary

In conclusion, Tactile Systems Technology Inc. stands at the forefront of medical innovation with an extensive array of high-quality medical devices, tailored support services, and skincare products designed for patients grappling with chronic diseases. Their specialized segments for lymphedema, venous insufficiency, and pressure ulcers, combined with committed support services, highlight the company’s dedication to enhancing patient outcomes and improving overall quality of life. Through its clinically validated products and comprehensive patient and clinical support offerings, Tactile Systems Technology continues to make a significant impact on the lives of millions of patients globally.